144 related articles for article (PubMed ID: 29582375)
21. Wharton's jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer.
Vulcano F; Milazzo L; Ciccarelli C; Eramo A; Sette G; Mauro A; Macioce G; Martinelli A; La Torre R; Casalbore P; Hassan HJ; Giampaolo A
Exp Cell Res; 2016 Jul; 345(2):190-8. PubMed ID: 27343631
[TBL] [Abstract][Full Text] [Related]
22. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-mesenchymal transition during invasion of cutaneous squamous cell carcinoma is paralleled by AKT activation.
Barrette K; Van Kelst S; Wouters J; Marasigan V; Fieuws S; Agostinis P; van den Oord J; Garmyn M
Br J Dermatol; 2014 Nov; 171(5):1014-21. PubMed ID: 24628329
[TBL] [Abstract][Full Text] [Related]
24. Targeted Therapy Against the Cell of Origin in Cutaneous Squamous Cell Carcinoma.
Goldie SJ; Chincarini G; Darido C
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060263
[TBL] [Abstract][Full Text] [Related]
25. Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers.
Hardin H; Montemayor-Garcia C; Lloyd RV
Hum Pathol; 2013 Sep; 44(9):1707-13. PubMed ID: 23528862
[TBL] [Abstract][Full Text] [Related]
26. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
Wei XD; Zhou L; Cheng L; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
[TBL] [Abstract][Full Text] [Related]
27. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
[TBL] [Abstract][Full Text] [Related]
28. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of stem cell marker CD133 expression in colorectal cancer.
Wang BB; Li ZJ; Zhang FF; Hou HT; Yu JK; Li F
Histol Histopathol; 2016 Mar; 31(3):299-306. PubMed ID: 26442717
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-142-5p induces cancer stem cell-like properties of cutaneous squamous cell carcinoma via inhibiting PTEN.
Bai X; Zhou Y; Chen P; Yang M; Xu J
J Cell Biochem; 2018 Feb; 119(2):2179-2188. PubMed ID: 28857248
[TBL] [Abstract][Full Text] [Related]
32. WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma.
Zimmerli D; Cecconi V; Valenta T; Hausmann G; Cantù C; Restivo G; Hafner J; Basler K; van den Broek M
Oncogene; 2018 Jul; 37(27):3753-3762. PubMed ID: 29662191
[TBL] [Abstract][Full Text] [Related]
33. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
[TBL] [Abstract][Full Text] [Related]
34. Expression of claudin-11 by tumor cells in cutaneous squamous cell carcinoma is dependent on the activity of p38δ.
Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Farshchian M; Kivisaari A; Kallajoki M; Raiko L; Peltonen J; Peltonen S; Kähäri VM
Exp Dermatol; 2017 Sep; 26(9):771-777. PubMed ID: 27992079
[TBL] [Abstract][Full Text] [Related]
35. Isolation and identification of a distinct side population cancer cells in the human epidermal squamous cancer cell line A431.
Geng S; Wang Q; Wang J; Hu Z; Liu C; Qiu J; Zeng W
Arch Dermatol Res; 2011 Apr; 303(3):181-9. PubMed ID: 21240514
[TBL] [Abstract][Full Text] [Related]
36. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE
Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319
[TBL] [Abstract][Full Text] [Related]
37. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
[TBL] [Abstract][Full Text] [Related]
38. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
39. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
40. CD24+ tumor-initiating cells from oral squamous cell carcinoma induce initial angiogenesis in vivo.
Zimmerer RM; Ludwig N; Kampmann A; Bittermann G; Spalthoff S; Jungheim M; Gellrich NC; Tavassol F
Microvasc Res; 2017 Jul; 112():101-108. PubMed ID: 28344048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
